Mylan Ducks $15M Bristol-Myers Contract Suit Over HIV Drug
Mylan Inc. on Monday dodged a $15 million breach of contract suit from Bristol-Myers Squibb Co. after a New York federal judge found that an agreement between the companies didn't bar...To view the full article, register now.
Already a subscriber? Click here to view full article